These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 37587888)

  • 1. The role of synthetic ligand of PPARα in regulation of transcription of genes related to mitochondria biogenesis and dynamic in an animal model of Alzheimer's disease.
    Żulińska S; Strosznajder AK; Strosznajder JB
    Folia Neuropathol; 2023; 61(2):138-143. PubMed ID: 37587888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A ligand-induced structural change in fatty acid-binding protein 1 is associated with potentiation of peroxisome proliferator-activated receptor α agonists.
    Patil R; Mohanty B; Liu B; Chandrashekaran IR; Headey SJ; Williams ML; Clements CS; Ilyichova O; Doak BC; Genissel P; Weaver RJ; Vuillard L; Halls ML; Porter CJH; Scanlon MJ
    J Biol Chem; 2019 Mar; 294(10):3720-3734. PubMed ID: 30598509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP.
    Corbett GT; Gonzalez FJ; Pahan K
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8445-50. PubMed ID: 26080426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diminished Hepatocarcinogenesis by a Potent, High-Affinity Human PPARα Agonist in PPARA-Humanized Mice.
    Foreman JE; Koga T; Kosyk O; Kang BH; Zhu X; Cohen SM; Billy LJ; Sharma AK; Amin S; Gonzalez FJ; Rusyn I; Peters JM
    Toxicol Sci; 2021 Aug; 183(1):70-80. PubMed ID: 34081128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species Differences between Mouse and Human PPARα in Modulating the Hepatocarcinogenic Effects of Perinatal Exposure to a High-Affinity Human PPARα Agonist in Mice.
    Foreman JE; Koga T; Kosyk O; Kang BH; Zhu X; Cohen SM; Billy LJ; Sharma AK; Amin S; Gonzalez FJ; Rusyn I; Peters JM
    Toxicol Sci; 2021 Aug; 183(1):81-92. PubMed ID: 34081146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPAR-α Agonist GW7647 Protects Against Oxidative Stress and Iron Deposit via GPx4 in a Transgenic Mouse Model of Alzheimer's Diseases.
    Qu XX; He JH; Cui ZQ; Yang T; Sun XH
    ACS Chem Neurosci; 2022 Jan; 13(2):207-216. PubMed ID: 34965724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin Induces Lysosomal Biogenesis and Attenuates Amyloid Plaque Pathology in a Mouse Model of Alzheimer's Disease via PPARα.
    Chandra S; Jana M; Pahan K
    J Neurosci; 2018 Jul; 38(30):6682-6699. PubMed ID: 29967008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of PPARα by APP in Alzheimer disease affects the pharmacological modulation of synaptic activity.
    Sáez-Orellana F; Leroy T; Ribeiro F; Kreis A; Leroy K; Lalloyer F; Baugé E; Staels B; Duyckaerts C; Brion JP; Gailly P; Octave JN; Pierrot N
    JCI Insight; 2021 Aug; 6(16):. PubMed ID: 34228639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel MicroRNA-455-3p and its protective effects against abnormal APP processing and amyloid beta toxicity in Alzheimer's disease.
    Kumar S; Reddy AP; Yin X; Reddy PH
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2428-2440. PubMed ID: 31181293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Novel Role of PPAR Alpha in the Brain: Promising Target in Therapy of Alzheimer's Disease and Other Neurodegenerative Disorders.
    Wójtowicz S; Strosznajder AK; Jeżyna M; Strosznajder JB
    Neurochem Res; 2020 May; 45(5):972-988. PubMed ID: 32170673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of reduced dynamin-related protein 1 against amyloid beta-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease.
    Manczak M; Kandimalla R; Fry D; Sesaki H; Reddy PH
    Hum Mol Genet; 2016 Dec; 25(23):5148-5166. PubMed ID: 27677309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Pedrós I; Petrov D; Allgaier M; Sureda F; Barroso E; Beas-Zarate C; Auladell C; Pallàs M; Vázquez-Carrera M; Casadesús G; Folch J; Camins A
    Biochim Biophys Acta; 2014 Sep; 1842(9):1556-66. PubMed ID: 24887203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription of genes involved in fat metabolism in chicken embryos exposed to the peroxisome proliferator-activated receptor alpha (PPARα) agonist GW7647 or to perfluorooctane sulfonate (PFOS) or perfluorooctanoic acid (PFOA).
    Strömqvist M; Olsson JA; Kärrman A; Brunström B
    Comp Biochem Physiol C Toxicol Pharmacol; 2012 Jun; 156(1):29-36. PubMed ID: 22465071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling of promoter occupancy by PPARalpha in human hepatoma cells via ChIP-chip analysis.
    van der Meer DL; Degenhardt T; Väisänen S; de Groot PJ; Heinäniemi M; de Vries SC; Müller M; Carlberg C; Kersten S
    Nucleic Acids Res; 2010 May; 38(9):2839-50. PubMed ID: 20110263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPAR-α agonist regulates amyloid-β generation via inhibiting BACE-1 activity in human neuroblastoma SH-SY5Y cells transfected with APPswe gene.
    Zhang H; Gao Y; Qiao PF; Zhao FL; Yan Y
    Mol Cell Biochem; 2015 Oct; 408(1-2):37-46. PubMed ID: 26092426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reverting Metabolic Dysfunction in Cortex and Cerebellum of APP/PS1 Mice, a Model for Alzheimer's Disease by Pioglitazone, a Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Agonist.
    Chang KL; Wong LR; Pee HN; Yang S; Ho PC
    Mol Neurobiol; 2019 Nov; 56(11):7267-7283. PubMed ID: 31016475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hederagenin improves Alzheimer's disease through PPARα/TFEB-mediated autophagy.
    Xie ZS; Zhao JP; Wu LM; Chu S; Cui ZH; Sun YR; Wang H; Ma HF; Ma DR; Wang P; Zhang XW; Zhang ZQ
    Phytomedicine; 2023 Apr; 112():154711. PubMed ID: 36809694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neural stem cell transplantation enhances mitochondrial biogenesis in a transgenic mouse model of Alzheimer's disease-like pathology.
    Zhang W; Gu GJ; Shen X; Zhang Q; Wang GM; Wang PJ
    Neurobiol Aging; 2015 Mar; 36(3):1282-92. PubMed ID: 25582749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of melatonin on mitochondrial biogenesis and mitochondrial structure and function in the HEK293-APPswe cell model of Alzheimer's disease.
    Wang CF; Song CY; Wang X; Huang LY; Ding M; Yang H; Wang P; Xu LL; Xie ZH; Bi JZ
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3542-3550. PubMed ID: 31081111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A map of the PPARα transcription regulatory network for primary human hepatocytes.
    McMullen PD; Bhattacharya S; Woods CG; Sun B; Yarborough K; Ross SM; Miller ME; McBride MT; LeCluyse EL; Clewell RA; Andersen ME
    Chem Biol Interact; 2014 Feb; 209():14-24. PubMed ID: 24269660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.